The aim of this worldwide study is to assess the safety and neutralizing activity of AZD5156 for prevention of COVID-19 in immunocompromised individuals compared to AZD7442 (EVUSHELD) in 3200 immunocompromised adults and adolescents 12 years of age or older (weighing at least 40 kg) in approximately 20 countries.
There are four sites in the UK, one in Manchester, two in London and another in Nottingham. Only the Manchester site is taking enquiries at the moment from patients wanting to participate. The contact details are as follows: Alison Uriel Email: Alison.Uriel@mft.nhs.uk. Address: Delaunays Rd, Crumpsall, Manchester M8 5RB, United Kingdom Phone: +44 161 795 4567
A full list of sites and more details regarding inclusion and exclusion criteria on the link here:
Thank you Jackie I had heard something about this.
Am I being dim but I can’t see which are the London hospitals listed, but worked out that IVIG excludes me from the first phase, so I wonder when the third phase will recruit ?
Unfortunately, I think your ivig treatment will exclude you from any trial as you probably have some passive immunity from that. The London hospitals weren't listed were they?
I could only see IVIG excluded in phase 1 but no mention of it for phase 3 !
Somewhere else a friend and fellow patient found the London post codes and thinks they are St Thomas and UCLH, so perhaps useful for any London members that meet the criteria to look out for updates.
Hi Jackie, I've emailed regarding this just waiting for a response from them. Probably be a while as many emails are going to be sent. Will let you know how I get on and if I get any further information. Thanks Sue xx
Hi Jackie thank you for this post. It looks like my age over 55 and the fact I am on Ibrutinib will exclude me at least from the first phase if I have read this correctly?
Jackie will correct me if I'm wrong, but I think the idea of the small phase 1 trial in healthy volunteers is to establish the safety profile of the new drug before it's unleashed on the 3,200 immune-compromised subjects in the main (phase 3) trial. So I don't expect the latter trial to get going for a few months yet, and that's the one you want to be in, as you stand a 50/50 chance of getting Evusheld Mk1 / Mk2.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.
FCR and immunosuppression
ALL of us with CLL are immune compromised, so what does it mean to be immunocompromised? Why does this increase our risk of coronavirus?
